Fate Therapeutics Inc.
[WKN: A1W50M | ISIN: US31189P1021]
Aktienkurse
1,616€ 1,22%
Echtzeit-Aktienkurs Fate Therapeutics Inc.
Bid: Ask:
Reuters Kategorien
dpa-AFX Compact / dpa-AFX PRO Kategorien
Traderfox: dpa-AFX ProFeed Kategorien
dpa-AFX ProFeed Kategorien

The Latest Analyst Ratings for Fate Therapeutics

Latest Ratings for FATE DateFirmActionFromTo Mar 2022HC Wainwright & Co.MaintainsBuy Dec 2021Morgan StanleyMaintainsEqual-Weight Dec 2021WedbushUpgradesNeutralOutperform …